Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | COR | NTRA | ICLR |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Cencora Inc | Natera Inc | Icon Plc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 186.54 | 396.14 | 240.95 | 163.83 | 196.67 |
| High | 188.32 | 400.03 | 243.64 | 169.71 | 203.97 |
| Low | 183.55 | 391.02 | 240.53 | 160.18 | 196.66 |
| Last | 187.90 | 397.48 | 243.20 | 167.88 | 203.67 |
| Change | +1.80 | +3.28 | +2.22 | +5.78 | +8.07 |
| % Change | +0.97% | +0.83% | +0.92% | +3.57% | +4.13% |
| Volume | 648,000 | 2,389,800 | 785,000 | 2,034,900 | 1,837,100 |
| 20-Day Average Volume | 890,825 | 2,015,435 | 1,282,925 | 1,508,475 | 2,101,925 |
| Previous Close | 186.10 | 394.20 | 240.98 | 162.10 | 195.60 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 193.83 | 413.43 | 239.74 | 135.20 | 213.95 |
| 20-Day Raw Stochastic | 21.33% | 15.08% | 64.59% | 96.51% | 34.19% |
| 20-Day Relative Strength | 45.39% | 30.12% | 57.01% | 70.76% | 32.07% |
| Weighted Alpha | -13.07 | -25.86 | +18.30 | +193.41 | -30.80 |
| Today's Opinion | 96% Sell | 100% Sell | 72% Buy | 100% Buy | 100% Sell |
| Previous Opinion | 96% Sell | 100% Sell | 72% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 56% Buy | 64% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.02% since 11/13/24 | -3.26% since 11/13/24 | -2.71% since 11/13/24 | +4.29% since 11/13/24 | -0.11% since 11/13/24 |
| Low | 183.35 on 11/15/24 | 391.02 on 11/20/24 | 237.48 on 11/15/24 | 143.20 on 11/15/24 | 183.38 on 11/18/24 |
| High | 208.10 on 11/14/24 | 414.36 on 11/14/24 | 249.10 on 11/14/24 | 169.71 on 11/20/24 | 204.80 on 11/14/24 |
| 1-Month | |||||
| %Chg | -4.99% since 10/18/24 | -7.73% since 10/18/24 | +2.43% since 10/18/24 | +37.16% since 10/18/24 | -31.59% since 10/18/24 |
| Low | 176.48 on 10/31/24 | 391.02 on 11/20/24 | 227.95 on 10/31/24 | 117.27 on 10/28/24 | 183.38 on 11/18/24 |
| High | 230.02 on 11/06/24 | 435.61 on 10/21/24 | 251.56 on 11/12/24 | 169.71 on 11/20/24 | 300.25 on 10/21/24 |
| 3-Month | |||||
| %Chg | -7.21% since 08/20/24 | -26.80% since 08/20/24 | +2.01% since 08/20/24 | +41.73% since 08/20/24 | -37.14% since 08/20/24 |
| Low | 176.48 on 10/31/24 | 391.02 on 11/20/24 | 218.65 on 10/07/24 | 110.57 on 09/06/24 | 183.38 on 11/18/24 |
| High | 230.02 on 11/06/24 | 567.26 on 09/03/24 | 251.56 on 11/12/24 | 169.71 on 11/20/24 | 328.35 on 08/26/24 |
| 6-Month | |||||
| %Chg | -15.76% since 05/20/24 | -26.61% since 05/20/24 | +10.05% since 05/20/24 | +57.92% since 05/20/24 | -36.10% since 05/20/24 |
| Low | 176.48 on 10/31/24 | 391.02 on 11/20/24 | 214.77 on 05/29/24 | 92.14 on 08/05/24 | 183.38 on 11/18/24 |
| High | 254.15 on 08/01/24 | 567.26 on 09/03/24 | 251.56 on 11/12/24 | 169.71 on 11/20/24 | 347.72 on 07/16/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,608,454 | 92,184,760 | 47,921,832 | 22,163,684 | 16,801,758 |
| Shares Outstanding, K | 51,136 | 231,923 | 197,047 | 132,021 | 82,495 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 293,958,590,000 | 1,082,570,000 | 8,120,180,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 1,509,120,000 | -434,800,000 | 612,340,000 |
| Last Quarter Sales | 1,009,760,000 | 45,106,000,000 | 79,050,110,000 | 439,760,000 | 2,030,030,000 |
| Last Quarter Net Income | 69,280,000 | 1,016,000,000 | 3,380,000 | -31,590,000 | 197,130,000 |
| 60-Month Beta | 1.38 | 0.85 | 0.44 | 1.53 | 1.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.59 on 11/06/24 | 8.37 on 10/17/24 | 3.34 on 11/06/24 | -0.26 on 11/12/24 | 3.35 on 10/23/24 |
| Latest Earnings Date | 11/06/24 | 10/17/24 | 11/06/24 | 11/12/24 | 10/23/24 |
| Most Recent Dividend | N/A | 1.630 on 09/10/24 | 0.550 on 11/15/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 12/05/24 | 11/15/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 18.39 | 11.34 | 17.51 | 0.00 | 14.37 |